* Genetic Vulnerability to Health Conditions and Inherited Conditions reports from tellmeGen tellmeGen's Advanced Genetic Analysis includes vulnerability to health conditions and inherited conditions reports. Advanced genetic analysis uses qualitative genotyping to detect clinically relevant variants in genomic DNA from saliva to report genetic vulnerability and carrier status. The information although useful is not intended to diagnose any disease. Ethnicity may affect the relevance of each report and how genetic vulnerability results are interpreted. Each genetic vulnerability report describes whether a person has variants associated with an increased vulnerability to develop a disease, but does not describe the overall risk of developing the disease. The test is not intended to inform current health status or to make medical decisions, including medication or treatment. Reports of inherited conditions can determine whether a person is a carrier of a genetic variant, but not whether he or she has two copies of any genetic variant. These reports are not intended to inform about future risk of developing a disease, the health of the fetus, or the risk of disease in the newborn child. Caveats and Limitations: tellmeGen's Genetic Vulnerability Report for BRCA1/BRCA2 reports on 832 variants in the BRCA1 and BRCA2 genes. The report describes whether a person's genetic outcome is associated with an increased vulnerability to develop breast and ovarian cancer, and may be associated with an increased vulnerability to prostate, pancreatic, and other cancers. The variants included do not represent the totality of BRCA1/BRCA2 variants in people of most ethnicities. This report does not include variants in other genes related to hereditary cancers and the absence of variants does not rule out the presence of other genetic variants that may impact cancer risk. This report is for non-prescription information and provides genetic information to discuss with a healthcare professional. Results should be confirmed in a clinical setting before any medical action is taken. tellmeGen Pharmacogenetics Reports tellmeGen's Advanced Genetic Analysis uses qualitative genotyping to detect variants in several genes in adult genomic DNA from saliva to inform the processing of certain medications and facilitate discussions with a healthcare professional. It does not describe whether or not a person will respond to a specific drug. Our pharmacogenetics report provides information on variants associated with the metabolism of some drugs and on the potential effect of therapies with certain drugs. The results should be confirmed by an independent genetic test prescribed by your healthcare provider before taking any medical action.Caution: The information in the advanced test should not be used to start, stop or change any treatment and does not analyze all possible variants that may affect protein metabolism or function. The tellmeGen advanced genetic test is not a substitute for a visit with a healthcare professional. Changing your current treatment may lead to harmful side effects or reduce the expected benefits of your medication, so consult with your healthcare professional before taking any medical action.

Haven't you taken a DNA test yet?

Get your genetic test and find out all about yourself.